The bradykinin antagonist Hoe 140 inhibits carrageenan- and thermically induced paw oedema in rats.

R Satoh , M Inazu , K J Wirth , H G Alpermann
Agents and actions 428 -431

31
1992
Atrial-selective antiarrhythmic actions of novel Ikur vs. Ikr, Iks, and IKAch class Ic drugs and beta blockers in pigs

Karsten Knobloch , Markus Bleich , Björn Rosenstein , Klaus J. Wirth
Medical Science Monitor 10 ( 7)

30
2004
ATP-Sensitive Potassium Channel Blocker HMR 1883 Reduces Mortality and Ischemia-Associated Electrocardiographic Changes in Pigs with Coronary Occlusion

Bernward A. Schölkens , Heinrich C. Englert , Björn Rosenstein , Klaus J. Wirth
Journal of Pharmacology and Experimental Therapeutics 291 ( 2) 474 -481

36
1999
Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

Carmen Scheibenbogen , Klaus J. Wirth
Journal of Translational Medicine 19 ( 1) 162 -162

2021
Kinin receptor antagonists: unique probes in basic and clinical research

Klaus J. Wirth , Hoiger Heitsch , Bernward A. Schöikens
Canadian Journal of Physiology and Pharmacology 73 ( 7) 797 -804

33
1995
Effect of Obstructive Respiratory Events on Blood Pressure and Renal Perfusion in a Pig Model for Sleep Apnea

Dominik Linz , Felix Mahfoud , Benedikt Linz , Mathias Hohl
American Journal of Hypertension 27 ( 10) 1293 -1300

38
2014
Effects of a novel amiodarone-like compound SAR114646A on the pig atrium and susceptibility to ventricular fibrillation in dogs and pigs.

George E. Billman , Heinz Gögelein , Hartmut Ruetten , Klaus J. Wirth
Naunyn-schmiedebergs Archives of Pharmacology 385 ( 4) 373 -384

2
2012
24
2001
Effect of the cardioselective, sarcolemmal K(ATP) channel blocker HMR 1098 on atrial electrical remodeling during pacing-induced atrial fibrillation in dogs.

András Vereckei , Heinz Gögelein , Klaus J. Wirth , Douglas P. Zipes
Cardiovascular Drugs and Therapy 18 ( 1) 23 -30

6
2004
Efficacy and tolerability of Icatibant (Hoe 140) in patients with moderately severe chronic bronchial asthma.

Akbar M. Akbary , Klaus J. Wirth , Bernward A. Schölkens
Immunopharmacology 33 ( 33) 238 -242

82
1996
Amyloid β-(1–40) stimulates cyclic GMP production via release of kinins in primary cultured endothelial cells

Klaus J. Wirth , Edwin Fink , Karl Rudolphi , Holger Heitsch
European Journal of Pharmacology 382 ( 1) 27 -33

8
1999
The bradykinin B2 receptor antagonist WIN 64338 inhibits the effect of des-Arg9-bradykinin in endothelial cells.

Klaus J. Wirth , Bernward A. Schölkens , Gabriele Wiemer
European Journal of Pharmacology 288 ( 1)

14
1994
Inhibition of rats adjuvant arthritis by a bradykinin antagonist Hoe 140 and its influence on kallikreins.

Jagdish N. Sharma , Klaus J. Wirth
General Pharmacology-the Vascular System 27 ( 1) 133 -136

23
1996
Role of Kinins in the Control of Renal Papillary Blood Flow, Pressure Natriuresis, and Arterial Pressure

Jerónimo Tornel , María Isabel Madrid , Miguel García-Salom , Klaus J. Wirth
Circulation Research 86 ( 5) 589 -595

34
2000
Differences in the atrial actions of Ikur-, Ikr- and Iks-blockers in the pig

J. Brendel , K. J. Wirth , K. Knobloch , A. E. Busch
Naunyn-Schmiedeberg's Archives of Pharmacology 365(Supplement 1 65

2002
The kinin antagonist Hoe 140 reduces acute paw oedema in rats caused by carrageenan, bradykinin and kaolin

J. N. Sharma , A. P. M. Yusof , K. J. Wirth
Inflammopharmacology 6 ( 1) 9 -17

13
1998
DesArg10[Hoe 140] is a potent B1 bradykinin antagonist.

Schölkens Ba , Wiemer G , Wirth Kj
Agents and actions 406

10
1992